Đang chuẩn bị liên kết để tải về tài liệu:
Prediction of anti-CD25 and 5-FU treatments efficacy for pancreatic cancer using a mathematical model
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with rising incidence and with 5- years overall survival of less than 8%. PDAC creates an immune-suppressive tumor microenvironment to escape immune-mediated eradication. |